357 related articles for article (PubMed ID: 30897154)
21. Nuclear receptors in macrophages: a link between metabolism and inflammation.
Szanto A; Roszer T
FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
[TBL] [Abstract][Full Text] [Related]
22. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
Sugden MC; Holness MJ
Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
[TBL] [Abstract][Full Text] [Related]
23. The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease.
Yang Z; Danzeng A; Liu Q; Zeng C; Xu L; Mo J; Pingcuo C; Wang X; Wang C; Zhang B; Zhang B
Int J Biol Sci; 2024; 20(1):113-126. PubMed ID: 38164174
[TBL] [Abstract][Full Text] [Related]
24. Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response.
Nagy L; Szanto A; Szatmari I; Széles L
Physiol Rev; 2012 Apr; 92(2):739-89. PubMed ID: 22535896
[TBL] [Abstract][Full Text] [Related]
25. Orphan nuclear receptors find a home in the arterial wall.
Laffitte BA; Tontonoz P
Curr Atheroscler Rep; 2002 May; 4(3):213-21. PubMed ID: 11931719
[TBL] [Abstract][Full Text] [Related]
26. The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome.
Pu S; Wu X; Yang X; Zhang Y; Dai Y; Zhang Y; Wu X; Liu Y; Cui X; Jin H; Cao J; Li R; Cai J; Cao Q; Hu L; Gao Y
Curr Drug Metab; 2019; 20(1):15-22. PubMed ID: 29886826
[TBL] [Abstract][Full Text] [Related]
27. Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
Fuchs CD; Traussnigg SA; Trauner M
Semin Liver Dis; 2016 Feb; 36(1):69-86. PubMed ID: 26870934
[TBL] [Abstract][Full Text] [Related]
28. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
Chinetti G; Fruchart JC; Staels B
Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
[TBL] [Abstract][Full Text] [Related]
30. Nuclear receptors, mitochondria and lipid metabolism.
Alaynick WA
Mitochondrion; 2008 Sep; 8(4):329-37. PubMed ID: 18375192
[TBL] [Abstract][Full Text] [Related]
31. Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma.
Nakaya K; Ayaori M; Hisada T; Sawada S; Tanaka N; Iwamoto N; Ogura M; Yakushiji E; Kusuhara M; Nakamura H; Ohsuzu F
J Atheroscler Thromb; 2007 Jun; 14(3):133-41. PubMed ID: 17587765
[TBL] [Abstract][Full Text] [Related]
32. Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.
Ramón-Vázquez A; de la Rosa JV; Tabraue C; Lopez F; Díaz-Chico BN; Bosca L; Tontonoz P; Alemany S; Castrillo A
Mol Cell Biol; 2019 Mar; 39(5):. PubMed ID: 30602495
[TBL] [Abstract][Full Text] [Related]
33. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
34. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
35. Modulation of xenobiotic receptors by steroids.
Banerjee M; Robbins D; Chen T
Molecules; 2013 Jun; 18(7):7389-406. PubMed ID: 23884115
[TBL] [Abstract][Full Text] [Related]
36. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.
Chinetti G; Zawadski C; Fruchart JC; Staels B
Biochem Biophys Res Commun; 2004 Jan; 314(1):151-8. PubMed ID: 14715259
[TBL] [Abstract][Full Text] [Related]
37. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
Chinetti-Gbaguidi G; Staels B
Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
[TBL] [Abstract][Full Text] [Related]
38. Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages.
Mota AC; Dominguez M; Weigert A; Snodgrass RG; Namgaladze D; Brüne B
Front Immunol; 2021; 12():637778. PubMed ID: 34025647
[TBL] [Abstract][Full Text] [Related]
39. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
40. Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors.
Shin DJ; Wang L
Handb Exp Pharmacol; 2019; 256():51-72. PubMed ID: 31230143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
